Product Details

CAT No.# CS-P-00367
Category Impurities
CAS 51372-29-3
Molecular Weight 430.55
Molecular Formula C25H34O6
Stock Status: In-Stock
Purity: >98%
Solubility: Chloroform, DMSO
Appearance: Light Beige Solid
Synonyms: (22R)-Budesonide;22(R)Budesonide Peak-I;Dexbudesonide;(11β,16α)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione;(11β,16α)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione; Dexbudesonide;
Application Notes: Budesonide epimer R. Budesonide 22R epimer is more active than 22S epimer. Used as an antiinflammatory agent.
References: Ryrfeldt., A., et a.: J. Steroid Biochem., 10, 317 (1979), Roth, G., et al.: J. Pharm. Sci., 69, 766 (1980), Clissold, S.P., et al.: Drugs, 28, 485 (1984),
Storage: Hygroscopic, -20°C Freezer, Under inert atmosphere
Shipping: Free Shipping for worldwide on order above 2000 USD
COA:    View COA
(22R)-Budesonide Worldwide Suppliers of (22R)-Budesonide Impurities Clearsynth CS-P-00367

Product rating: 9 (22R)-Budesonide based on 20 ratings

  1. Impurities
  2. (22R)-Budesonide

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Nandrolone Decanoate EP impurity F
15. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
16. Ortho toluene sulfonic acid
17. Sucrose (1623637)
18. Crisaborole m-Isomer
19. Riluzole (1604337)
20. Pheniramine impurity B


This page contains information about (22R)-Budesonide Cas 51372-29-3 and its Impurities.

(22R)-Budesonide (22R)-Budesonide Worldwide Suppliers of (22R)-Budesonide Impurities Clearsynth 51372-29-3

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."